Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Exp Neurol. 2013 Mar 15;247:328–341. doi: 10.1016/j.expneurol.2013.03.008

Table 1.

This table summarizes both the beneficial and adverse consequences of opioid administration in the Acute (D1–7) and Chronic (D7+) phases of spinal cord injury. In both phases, opioid administration results in pain relief. However, this pain relief is accompanied by numerous consequences.

Consequence of SCI or
Opioid Administration
Mechanisms Common to SCI and Opioid Administration
Decreased locomotor function Excitotoxic cell death Increased extracellular glutamate
Increased NMDAR activation
Increased dynorphin levels
Increased glial activation Release glutamate, ATP, CGRP, pro-inflammatory cytokines, ROS, NO
Apoptosis Initiated via activation of caspase-3, increased Bax and decreased Bcl-2 Causes release of pro-inflammatory cytokines
Pain development Central sensitization Increased NMDAR activation
Increased extracellular glutamate
OIH Increased NMDAR activation
Increased glutamate availability
Increased spinal dynorphin
Increased glial activation Release glutamate, ATP, CGRP, pro-inflammatory cytokines, ROS, NO, activation of MAPK pathways, TLR’s
Increased risk of infection Immune suppression, HPA dysregulation Decreased lymphocyte levels
Mortality Increased glial activation Increased pro-inflammatory cytokines